IPP Bureau
Haisco licenses two drug candidates to Nuvectis in potential $1.4 billion deal
By IPP Bureau - June 25, 2026
Nuvectis gains global rights outside select Asian markets for oncology and complement disease therapies, with Haisco eligible for milestone payments and royalties
Experts call for uniform quality standards for blood and blood components
By IPP Bureau - June 25, 2026
National conference brings together 160+ experts from six states to advance blood quality and safety standards
Mardamed unveils 15,000 sq. ft. HeX Centre integrating healthcare with everyday retail
By IPP Bureau - June 25, 2026
The company aims to make preventive and specialist healthcare as accessible as everyday retail experiences
AI moves from experimentation to enterprise tool across pharma value chain: GlobalData
By IPP Bureau - June 25, 2026
34% of pharma firms have already deployed function-specific AI, with drug discovery, clinical trials, and medical writing emerging as key high-impact use cases
Shilpa Medicare subsidiary settles Rs. 20.13 crore dispute with Sartorius for Rs. 9 crore
By IPP Bureau - June 25, 2026
The resolution significantly reduces a long-standing contingent liability from the company's books
Mankind Pharma launches nationwide preventive oncology initiative to reach one million women
By IPP Bureau - June 25, 2026
Partnership with MAMTA HIMC aims to boost awareness, screening, HPV vaccination, and early detection of breast and cervical cancer in underserved communities
Eli Lilly launches Tanstrive in India for RET-altered cancers
By IPP Bureau - June 25, 2026
CDSCO-approved targeted therapy expands precision oncology options for patients with RET-driven lung, thyroid, and other advanced solid tumours
Zealand Pharma’s petrelintide delivers double-digit weight loss in next-gen obesity treatment
By IPP Bureau - June 24, 2026
As competition intensifies in the obesity treatment market, a next-generation therapy may be in development.
Teva study shows Huntington’s disease treatment improves life for patients & caregivers
By IPP Bureau - June 24, 2026
The findings come from the first and only decentralized real-world study examining how HD chorea affects patients and caregivers and how treatment impacts quality of life
Oval & Merck Specialities sign strategic pact to expand access to advanced IVF care in India
By IPP Bureau - June 24, 2026
The collaboration comes at a time when access to high-quality fertility treatment remains uneven, despite rapid market expansion
European Commission approves AbbVie's MAVIRET for acute Hepatitis C treatment
By IPP Bureau - June 24, 2026
Approval makes it the first and only therapy in the EU indicated for both acute and chronic hepatitis C, supported by Phase 3 data
Govt seeks stakeholder feedback on proposed changes to GTE exemption list for medical devices
By IPP Bureau - June 24, 2026
Industry members have until 15 July 2026 to submit feedback on proposals seeking additions, deletions and modifications to the Global Tender Enquiry
Biocon to supply insulin under Malaysia MoH contracts worth over Rs. 515 crore
By IPP Bureau - June 24, 2026
Partnership with Duopharma Biotech covers human insulin, insulin glargine and insulin aspart, supporting diabetes care and medicine security in Malaysia
Fortis Escorts Hospital launches robotic surgery institute in Faridabad
By IPP Bureau - June 24, 2026
New Centre of Excellence brings advanced robotic platforms and multidisciplinary expertise under one roof to expand access to precision-led minimally invasive surgery
SwishX selected for Anthropic-AWS Agentic AI Accelerator 2026
By IPP Bureau - June 24, 2026
Bengaluru-based startup recognised for building autonomous AI agents for pharmaceutical and medtech commercial operations, joins select cohort of 40 startups in India-focused accelerator programme
